AHMAD MUHAMMAD: Open Payments
NPI 1225713076 · PARMA, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,037 in 21 payments from 10 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $1,037
Food & beverage: $969Education: $68
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 8 | $287 |
| ConvaTec Inc. | 2 | $154 |
| IMMUNITYBIO, INC. | 2 | $153 |
| Teleflex LLC | 1 | $144 |
| BLUEWIND MEDICAL | 1 | $140 |
| Sumitomo Pharma America, Inc. | 3 | $62 |
| UROGEN PHARMA, INC. | 1 | $34 |
| AstraZeneca Pharmaceuticals LP | 1 | $24 |
| Merck Sharp & Dohme LLC | 1 | $23 |
| Ferring Pharmaceuticals Inc. | 1 | $16 |
Products named: ERLEADA, GENTLECATH GLIDE, ANKTIVA, BARRIGEL, REVI, RYBREVANT, GEMTESA, LYNPARZA.
Industry payments across OH — which companies pay providers there.
